Digital/Electrical Sphygmomanometer Market By Product Type (Upper Arm, Wrist Type), By Technology (Full-Automatic, Semi-Automatic), By Portability (Portable, Non-Portable), By End-User (Hospitals And Clinics, Ambulatory Care Centers, Home Care Settings, Others), by geography is expected to grow at a steady CAGR forecast till 2027 owing to rising cases of blood-related disorders and rapid evolution of advanced devices.

The Global Digital/Electrical Sphygmomanometer market was valued at USD 977.78 million in 2021, growing at a CAGR of 10.57%% during the forecast period from 2022 to 2027 to reach USD 1,783.88 million by 2027. The Digital/Electrical Sphygmomanometer market is witnessing a positive market growth owing to the factors such as the rising cases of blood-related disorders like high blood pressure and hypertension, rapid evolution and technological advancements in product development, increasing aging population who are more prone to hypertension risk.

Digital/Electrical Sphygmomanometer Market Dynamics:

One of the main drivers of the Digital/Electrical Sphygmomanometer market is the rising cases of blood-related disorders such as hypertension. As per the latest data provided by the WHO, 2021, approximately 1.28 billion adults in the 30-79 year age group are currently living with hypertension globally with the majority of the patient population (two-thirds) present in the low and middle-income countries. It has been established that increased blood pressure has been associated with the increased diagnosis which will lead to more and more prevalence of blood-related or cardiovascular diseases. This ultimately will contribute to the Digital/Electrical Sphygmomanometer market growth progression over time.

Moreover, as per the data provided by the World Health Organization, cardiovascular diseases (CVDs) are the leading cause of death across the globe, wherein this group of disease-account for an estimated 17.9 million lives each year.

Moreover, according to the data provided by the European Society for Cardiology (ESC), each year cardiovascular disease (CVD) causes 3.9 million deaths in Europe and over 1.8 million deaths in the European Union. They represent about 45% of all deaths in Europe and 37% in the EU. Therefore, the demand for Digital/Electrical Sphygmomanometer is set to witness an increased growth owing to the increasing prevalence of blood-related disorders like CVDs, thereby positively impacting the Digital/Electrical Sphygmomanometer market growth during the forecast period (2022-2027).

Another key factor responsible for the growth of the Digital/Electrical Sphygmomanometer market is the increasing geriatric population base across the globe. According to the data provided by the World Health Organization, in 2020, about one billion people across the world were over the age of 60. The source further stated that by 2050, the elderly population in the 60 and above age group is expected to double in number representing about 2.1 billion people, and people in the age group of 80 and above are estimated to triple between 2020 and 2050 to reach 426 million. The elderly population is more prone to developing high blood pressure which is ultimately associated with developing CVDs or other diseases, therefore, the rising elderly population is expected to lead to the rise in the patient population of cardiovascular diseases across the world, which in turn would lead to an increase in demand for Digital/Electrical Sphygmomanometer in the forecast period (2022-2027), which will drive the Digital/Electrical Sphygmomanometer market growth.

Along with the factors mentioned above, technological advancements in the field of Digital/Electrical Sphygmomanometer such as the development of new techniques to enhance the yield and diagnostic accuracy are also expected to aid in the growth of the Digital/Electrical Sphygmomanometer market. For instance, in January 2022, Aktiia announced a landmark hypertension trial in the United States in collaboration with a top US hypertension center, for its world's 24/7 blood pressure monitor, which automatically gathers over 100x the data and has over 10x the engagement of other blood pressure monitors.
However, certain factors like the high cost of devices and Digital/Electrical Sphygmomanometer being very sensitive due to which body movements affect its accuracy, or some devices only work on the left arm are expected to restrain the growth of this market. Moreover, the need for continuous recalibration of the devices may be certain limiting factors of the Digital/Electrical Sphygmomanometer market growth.

Moreover, the impact of the COVID-19 pandemic was positive on the Digital/Electrical Sphygmomanometer market. COVID-19 outbreak extensively instigated increased use of Digital/Electrical Sphygmomanometer as it was used as an essential procedure in events of complications to rule out issues associated with COVID-19. This resulted in the increased demand for Digital/Electrical Sphygmomanometer during the pandemic. Therefore, the market for Digital/Electrical Sphygmomanometer had a positive growth rate during the COVID-19 pandemic.

Digital/Electrical Sphygmomanometer Market Segment Analysis:

Digital/Electrical Sphygmomanometer Market By Product Type (Upper Arm, Wrist Type), By Technology (Full-Automatic, Semi-Automatic), By Portability (Portable, Non-Portable), By End-User (Hospitals and Clinics, Ambulatory Care Centers, Home Care Settings, Others), and By Geography (North America, Europe, Asia-Pacific, And Rest of the World)

In the Product Type segment of the Digital/Electrical Sphygmomanometer market, the Portable Digital/Electrical Sphygmomanometer is estimated to hold a significant share in the Digital/Electrical Sphygmomanometer market during the forecast period (2022-2027). This can be attributed to the specific features associated with these devices. The rapid growth of this product segment can be attributed to the growing demand for early and accurate diagnosis and leads to the high adoption of these devices. Further, the growing adoption of Portable Digital/Electrical Sphygmomanometer by hospitals and the in-home healthcare sector around the world is also driving the market growth.

Since the beginning of the COVID-19 pandemic, the demand for portable Digital/Electrical Sphygmomanometer has been on the rise. Portable Digital/Electrical Sphygmomanometer provides high-quality tracings that can be achieved both at home and in the office setting. Also, Portable Digital/Electrical Sphygmomanometer are an important contribution to epidemiologic and clinical studies that require frequent measures of a more broad range of cardiology function parameters. Therefore, the growing demand for disease diagnosis and treatment benefits the segment growth of the Digital/Electrical Sphygmomanometer market. Hence, their reliability has constantly increased with time and advancements in the newer generation of devices. Therefore, considering the advantages associated with Portable Digital/Electrical Sphygmomanometer, this category is expected to generate significant revenue share eventually contributing to the overall growth of the global Digital/Electrical Sphygmomanometer market during the forecast period.

North America is expected to dominate the overall Digital/Electrical Sphygmomanometer Market:

Among all the regions, North America is expected to account for the largest share in the global Digital/Electrical Sphygmomanometer market. Factors such as the high risk of blood pressure and hypertension among the population, technological advancement in product development, and increased product launches are expected to aid in the growth of the North America Digital/Electrical Sphygmomanometer Market in this region.

As per the data provided by the Centers for Disease Control and Prevention, as of 2021, High blood pressure, high blood cholesterol, and smoking are key risk factors for heart disease. About half of people in the United States (47%) have at least one of these three risk factors.

Additionally, according to the data of the American Heart Association 2021, in the year 2018, Coronary Heart Disease (CHD) was the leading cause (42.1%) of deaths in the US, attributable to high blood pressure (11.0%), Heart failure (9.6%), diseases of the arteries (2.9%), and others (17.4%).

Therefore, the rising risk factors of blood-related disorders in the country would result in the rising demand for treatments that make use of Digital/Electrical Sphygmomanometer, which in turn would provide a conducive growth environment for the United States Digital/Electrical Sphygmomanometer market as well as the North American region.

Furthermore, the increased emphasis on product development activities and high interest of device manufacturers in accessing local markets further aid in the growth of the regional markets for Digital/Electrical Sphygmomanometer. For instance, in march 2021, Qardio, Inc. announced the US Food and Drug Administration (FDA) 510k clearance for its QardioCore ambulatory ECG device. QardioCore extended Qardio's remote patient monitoring platform from primary care and hypertension monitoring to acute care and cardiology, in a single, intuitive platform.

The product launches in the local markets correlate to a significant reduction in costs thereby making them affordable for end-users which in turn drives the product demand in the market. Therefore, the interplay of various factors such as the presence of a large patient population, as well as new product launches in the region is expected to boost the North America Digital/Electrical Sphygmomanometer market during the forecast period.  

Digital/Electrical Sphygmomanometer Market Key Players:

Some of the key market players operating in the Digital/Electrical Sphygmomanometer market include OMRON Healthcare, Inc., Hill-Rom Services, Inc., A&D Company Limited, SunTech Medical, Inc., American Diagnostic Corporation, Withings, General Electric Company, Microlife Corporation, GF Health Products, Inc., Spacelabs Healthcare, Rudolf Riester GmbH, Contec Medical Systems Co., Ltd., ARCHOS™, Panasonic Corporation, Yuwell-Jiangsu Yuyue medical equipment & supply Co., Ltd., ERKA Kallmeyer Medizintechnik GmbH & Co. KG., BOSCH + SOHN GmbH u. Co. KG., Beijing Choice Electronic Tech Co., Ltd, Koninklijke Philips N.V., SPENGLER HOLTEX Group and others.

Recent Developmental Activities in the Digital/Electrical Sphygmomanometer Market:

• In February 2022, Abbott announced the US Food and Drug Administration (FDA) approval of an expanded indication for its CardioMEMS™ HF System to support the care of more people living with heart failure. The sensor provides an early warning system enabling doctors to protect against worsening heart failure.

• In November 2020, Blipcare developed a Wi-Fi blood pressure monitor and announced the availability of its new cellular blood pressure monitor, the Blip BP 800.

Key Takeaways from the Digital/Electrical Sphygmomanometer Market Report Study

● Market size analysis for current Digital/Electrical Sphygmomanometer market size (2021), and market forecast for 5 years (2022-2027)

● The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Digital/Electrical Sphygmomanometer market.

● Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

● Key companies dominating the global Digital/Electrical Sphygmomanometer market.

● Various opportunities available for the other competitor in the Digital/Electrical Sphygmomanometer market space.

● What are the top performing segments in 2021? How these segments will perform in 2027.

● Which is the top-performing regions and countries in the current Digital/Electrical Sphygmomanometer market scenario?

● Which are the regions and countries where companies should have concentrated on opportunities for Digital/Electrical Sphygmomanometer market growth in the coming future?

Target Audience who can be benefited from this Digital/Electrical Sphygmomanometer Market Report Study

● Digital/Electrical Sphygmomanometer products providers

● Research organizations and consulting companies

● Digital/Electrical Sphygmomanometer-related organizations, associations, forums, and other alliances

● Government and corporate offices

● Start-up companies, venture capitalists, and private equity firms

● Distributors and Traders dealing in Digital/Electrical Sphygmomanometer

● Various End-users who want to know more about the Digital/Electrical Sphygmomanometer market and latest technological developments in the Digital/Electrical Sphygmomanometer market.

Frequently Asked Questions for Digital/Electrical Sphygmomanometer Market:

1. What is a Digital/Electrical Sphygmomanometer?

Sphygmomanometers are medical devices that are used to measure blood pressure (mainly in arteries). These devices are of three types mainly mercury sphygmomanometers, an aneroid sphygmomanometer, and electronic/digital sphygmomanometer. A digital sphygmomanometer works on an oscillometric principle in which the blood pressure in an artery is measured by sensing arterial wall vibrations.

2. What is the market for Global Digital/Electrical Sphygmomanometer?

The Global Digital/Electrical Sphygmomanometer market was valued at USD 977.78 million in 2021, growing at a CAGR of 10.57%% during the forecast period from 2022 to 2027 to reach USD 1,783.88 million by 2027.

3. What are the drivers for the Global Digital/Electrical Sphygmomanometer Market?

The Digital/Electrical Sphygmomanometer market is witnessing a positive market growth owing to the factors such as the rising cases of blood-related disorders like high blood pressure and hypertension, rapid evolution and technological advancements in product development, increasing aging population who are more prone to hypertension risk.

4. Who are the key players operating in the Global Digital/Electrical Sphygmomanometer Market?

Some of the key market players operating in the Digital/Electrical Sphygmomanometer market include OMRON Healthcare, Inc., Hill-Rom Services, Inc., A&D Company Limited, SunTech Medical, Inc., American Diagnostic Corporation, Withings, General Electric Company, Microlife Corporation, GF Health Products, Inc., Spacelabs Healthcare, Rudolf Riester GmbH, Contec Medical Systems Co., Ltd., ARCHOS™, Panasonic Corporation, Yuwell-Jiangsu Yuyue medical equipment & supply Co., Ltd., ERKA Kallmeyer Medizintechnik GmbH & Co. KG., BOSCH + SOHN GmbH u. Co. KG., Beijing Choice Electronic Tech Co., Ltd, Koninklijke Philips N.V., SPENGLER HOLTEX Group and others.

5. Which region has the highest share in Digital/Electrical Sphygmomanometer Market?

North America is expected to hold the highest share in the revenue in the Digital/Electrical Sphygmomanometer market during the forecast period. Factors such as the high risk of blood pressure and hypertension among the population, technological advancement in product development, and increased product launches are also expected to aid in the Digital/Electrical Sphygmomanometer market growth in this region.